Browsing by Author Price, Karen N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 16 of 16
Issue DateTitleAuthor(s)Citation
2003Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breat cancer : a randomized trialCoates, Alan; Bonetti, Marco; Castiglione-Gertsch, Monica; Colleoni, Marco; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Nasi, M. Laura; O'Neill, Anne; Price, Karen N.; School of Public Health: Public HealthAdjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breat cancer : a randomized trial, Journal of the National Cancer Institute, vol.95,(24),2003,pp 1833-1846
2003Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IVCoates, Alan; Castiglione-Gertsch, Monica; Collins, John; Crivellari, Diana; Fey, Martin F.; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Lindtner, Jurji; Price, Karen N.; Rudenstam, Carl-Magnus; Senn, Hans-Jorg; School of Public Health: Public HealthAdjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV, Journal of Clinical Oncology, vol.21,(24),2003,pp 4517-4523
2010Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancerCoates, Alan; Cole, Bernard; Crivellari, Diana; Gelber, Richard; Gelber, Shari; Goldhirsch, A; Holmberg, Stig B.; Paridaens, Robert; Price, Karen N.; Thurlimann, B.; School of Public Health: Public HealthAdjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer, Breast Cancer Research and Treatment, vol.123, 1,pp 303-310
2011Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 studyCoates, Alan; Chirgwin, Jacquie H; Colleoni, Marco; Forbes, John F.; Gelber, Richard D. (Prof); Giobbie-Hurder, Anita; Goldhirsch, Aron (Prof); Lang, Istvan; Mauriac, L; Mouridsen, Henning; Paridaens, R.J.; Pienkowski, Tadeusz; Price, Karen N.; Regan, Meredith M.; Smith, Ian (Prof); Thurlimann, Beat; Wardley, Andrew; School of Public Health: Public HealthAnalyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study, Journal of Clinical Oncology, vol.29, 9, 2011,pp 1117-1124
2011Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-upCoates, Alan; Ejlertsen, Bent; Forbes, John F.; Gelber, Richard; Giobbie-Hurder, Anita; Goldhirsch, Aron; Lang, Istvan; Mauriac, Louis; Neven, Patrick; Price, Karen N.; Rabaglio, Manuela; Regan, Meredith M.; Smith, Ian (Prof); Thurlimann, B.; Wardley, Andrew; School of Public Health: Public HealthAssessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up, Lancet Oncology, vol.12, 12, 2011,pp 1101-1108
2008Chemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors-International Breast Cancer Study GroupCoates, Alan; Braye, Stephen; Brown, Robert; Castiglione-Gertsch, Monica; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Golouh, Rastko; Grigolato, Piergioranni; Gusterson, Barry A.; Kovacs, Aniko; Maiorano, Eugenio; Mastropasqua, Mauro G.; Ohlschlegel, Christian; Perin, Tiziana; Pillay, Komala; Price, Karen N.; Regan, Meredith M.; Rusca, Tiziana; Viale, Giuseppe; School of Public Health: Public HealthChemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors-International Breast Cancer Study Group, Journal of Clinical Oncology, vol.26, 9, 2008,pp 1404-1410
2010Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast CancerCoates, Alan; Cole, Bernard; Colleoni, Marco; Crivellari, Diana; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Gusterson, Barry; Maiorano, Eugenio; Mastropasqua, Mauro G.; Price, Karen N.; Regan, Meredith M.; Viale, Giuseppe; School of Public Health: Public HealthClassical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer, Journal of Clinical Oncology, vol.28, 18, 2010,pp 2966-2973
2008Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical TrialsCoates, Alan; Castiglione-Gertsch, Monica; Gelber, Richard D. (Prof); Goldhirsch, Aron; Gusterson, Barry A.; Holmberg, Stig B.; Lindtner, Jurii; Mallon, Elizabeth; Murray, E.; Pestalozzi, B. C.; Price, Karen N.; Snyder, Raymond; Thurlimann, Beat; Viale, Giuseppe; Zahrieh, David; School of Public Health: Public HealthDistinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials, Journal of Clinical Oncology, vol.26, 18, 2008,pp 3006-3014
2007Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Gelber, Richard D. (Prof); Gelber, Shari; Goldhirsch, Aron (Prof); International, B e; Pagani, O.; Price, Karen N.; Simoncini, Edda; School of Public Health: Public HealthEffects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93, Annals of Oncology 2005, vol.18,(7),2007,pp 1177-1184
2009Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.Coates, Alan; Castiglione-Gertsch, Monica; Collins, John; Crivellari, Diana; et al, various; Gelber, Richard D. (Prof); Gelber, Shari; Holmberg, Stig B.; Lindtner, Jurij; Pagani, O.; Price, Karen N.; Simoncini, Edda; Thurlimann, B.; School of Public Health: Public HealthIs adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93., Breast Cancer Research and Treatment, vol.116, 3,pp 491-500
2012Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 TrialCoates, Alan; Bonnefoi, Herve; Ejlertsen, Bent; et al, Various; Ewertz, Marianne; Forbes, John F.; Gray, Kathryn P; Paridaens, R.J.; Price, Karen N.; Rabaglio, Manuela; Regan, Meredith M.; Thurlimann, Beat; School of Public Health: Public HealthObesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial, Journal of Clinical Oncology, vol.30, 32, 2012,pp 3967-3975
2007The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancerCoates, Alan; Castiglione-Gertsch, Monica; Cole, Bernard; Collins, John; et, al; Gusterson, Barry; Holmberg, Stig B.; Karlsson, Per; Lindtner, Jurij; Murray, E.; Price, Karen N.; School of Public Health: Public HealthThe role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer, JOURNAL OF CLINICAL ONCOLOGY 2005, vol.25,(15),2007,pp 2019-2026
2009Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.Coates, Alan; Castiglione-Gertsch, Monica; Fantini, Manuela; Gelber, Richard D. (Prof); Gelber, Shari; Gianni, Lorenzo; Goldhirsch, A; Pagani, O.; Panzini, Ilaria; Price, Karen N.; Ravaioli, Alberto; Simoncini, Edda; School of Public Health: Public HealthSecond non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group., European Journal of Cancer, vol.45, 4,pp 561-571
2012Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancerCoates, Alan; Aldridge, Julie; Bernhard, J; Cardoso, Fatima; Gelber, Richard D. (Prof); Goldhirsch, A; Harvey, V; Pagani, Olivia; Phillips, Kelly-Anne; Price, Karen N.; Ribi, Karin; Thompson, Alastair; Thurlimann, Beat; School of Public Health: Public HealthSubjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer, British Journal of Cancer, vol.106, 10, 2012,pp 1618-1625
2006Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.Coates, Alan; Aebi, Stefan; Castiglione-Gertsch, Monica; Colleoni, Marco; Gelber, Richard D. (Prof); Gelber, Shari; Goldhirsch, Aron (Prof); International, B e; Price, Karen N.; School of Public Health: Public HealthTamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93., JOURNAL OF CLINICAL ONCOLOGY 2005, vol.24,(9),2006,pp 1332-1341
2016Treatment adherence and its impact on disease-free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequenceCoates, Alan; Chirgwin, Jacquie; Debled, Marc; Ejlertsen, Bent; et al, Various; Gelber, Richard D; Giobbie-Hurder, Anita; Goldhirsch, Aron; Price, Karen N.; Rabaglio, Manuela; Smith, Ian; School of Public Health: Public HealthTreatment adherence and its impact on disease-free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequence, Journal of Clinical Oncology, vol.34, 21, 2016,pp 2452-2459